openRxiv names Dr. Tracy Teal first CEO to advance open science
Scientist and nonprofit leader who previously led The Carpentries and Dryad to lead the organization that oversees bioRxiv and medRxiv. DAVIS, Calif., Aug. 19, 2025 /PRNewswire/ -- openRxiv announced today that after an extensive international search, its Board of Directors has appointed Dr. Tracy Teal as the organization's inaugural CEO. Dr. Teal has served as interim COO of openRxiv...
Ansell Receives Frost & Sullivan’s 2025 Global Sustainable Hospital Supplies Company of the Year Award
Ansell is recognised for its leadership in hospital supply sustainability, visionary innovation, and customer impact on a global scale. SAN ANTONIO, Aug. 18, 2025 /PRNewswire/ -- Frost & Sullivan, a leader in the information and growth advisory industry, has awarded the title of "2025 Global Sustainable Hospital Supplies Company of the Year" to Ansell, a global provider of safety...
Datasea Achieves Breakthrough in Acoustic Technology, Accelerating Billion-Dollar Commercialization in Healthcare
DTSS' Acoustic innovation Addresses the Healthcare Application Market Projected to Exceed $100 Billion in China and Approach $90 Billion Globally by 2030 BEIJING, Aug. 18, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada-based technology enterprise specializing in advanced acoustic high-tech products and AI multimodal digital solutions,...
Aon Announces Strategic Investment in eMed to Scale GLP-1 Population Health Platform
Strategic investment is accelerating the transformation of employer-focused obesity solutions to boost adherence, retention and deliver breakthrough health outcomes with cost savings DUBLIN, Aug. 18, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, today announced a strategic investment in eMed Population Health, Inc., an emerging leader in the delivery of GLP-1 programs. The partnership...
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taking the lead in business development, with several companies in the due diligence stage, and additional deals are anticipated. SEOUL, South Korea, Aug. 18, 2025 /PRNewswire/ -- Avixgen, a subsidiary of Dx&Vx, announced on the 18th that...
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
BEIJING, Aug. 18, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that its board of directors (the "Board") has received a preliminary non-binding proposal letter (the "Proposal...
KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS
Revenue reached approximately RMB950.4 million, with total commercial sales RMB309.8million, representing a significant increase in proportion Research and development expenses was approximately RMB611.5 million Loss for the period was RMB145.2 million; adjusted loss for the period was RMB69.4 million Cash and cash equivalents amounted to approximately RMB4527.8 million, reflecting ample...
India’s leading healthcare network Manipal Hospitals welcomes India’s leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR
NEW DELHI, Aug. 18, 2025 /PRNewswire/ -- Manipal Hospitals, one of India's leading and globally recognized healthcare institutions, welcomes one of India's most renowned robotic oncosurgeons, Dr. Surender Kumar Dabas as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster. With this addition, the hospital across...
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies
YONGIN, South Korea, Aug. 18, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced today that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Society (TRCS) to cooperate on workforce training for the production of plasma-derived medicinal products. This MOU formalizes and deepens a...
Next Generation Refractive Surgery to LASIK and SMILE Now Available for Clinical Review
Pioneer surgeon Dr Natasha Lim is among the first in Singapore to offer Smooth Incision Lenticular Keratomileusis (SILK) procedure in their clinics. SINGAPORE, Aug. 18, 2025 /PRNewswire/ -- Dr. Natasha Lim, an internationally renowned surgeon in Ophthalmology, has introduced an alternative to established refractive surgery techniques for medical practitioners in Singapore to explore. Smooth Incision Lenticule Keratomileusis (SILK), a recent...
